36. 表皮水疱症 Epidermolysis bullosa Clinical trials / Disease details


臨床試験数 : 163 薬物数 : 185 - (DrugBank : 46) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 125

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2009-010763-17-SE
(EUCTR)
26/05/200920/03/2009Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia congenita-a double-blind placebo-controlled phase II proof of concept studyBotulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia congenita-a double-blind placebo-controlled phase II proof of concept study Epidermolysis Bullosa Simplex and Pachyonychia CongenitaTrade Name: DysportSophiahemmetNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
Phase 2Sweden
2NCT00936533
(ClinicalTrials.gov)
May 20098/7/2009Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia CongenitaBotulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita - a Double-blind Placebo-controlled Phase II Proof of Concept StudyEpidermolysis Bullosa SimplexDrug: Dysport® (Botulinumtoxin A (Btx A));Drug: PlaceboUppsala UniversityNULLRecruiting16 YearsN/ABoth40Phase 2Sweden